- Home
- INZY vs GENC Comparison
INZY vs GENC Comparison
Compare INZY & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- GENC
- Stock Information
- Founded
- INZY 2015
- GENC 1894
- Country
- INZY United States
- GENC United States
- Employees
- INZY N/A
- GENC N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- GENC Construction/Ag Equipment/Trucks
- Sector
- INZY Health Care
- GENC Industrials
- Exchange
- INZY Nasdaq
- GENC Nasdaq
- Market Cap
- INZY 321.4M
- GENC 321.0M
- IPO Year
- INZY 2020
- GENC N/A
- Fundamental
- Price
- INZY $3.13
- GENC $21.34
- Analyst Decision
- INZY Strong Buy
- GENC
- Analyst Count
- INZY 7
- GENC 0
- Target Price
- INZY $16.14
- GENC N/A
- AVG Volume (30 Days)
- INZY 313.3K
- GENC 25.5K
- Earning Date
- INZY 11-05-2024
- GENC 12-11-2024
- Dividend Yield
- INZY N/A
- GENC N/A
- EPS Growth
- INZY N/A
- GENC 35.02
- EPS
- INZY N/A
- GENC 1.11
- Revenue
- INZY N/A
- GENC $113,116,000.00
- Revenue This Year
- INZY N/A
- GENC N/A
- Revenue Next Year
- INZY N/A
- GENC N/A
- P/E Ratio
- INZY N/A
- GENC $19.35
- Revenue Growth
- INZY N/A
- GENC 5.44
- 52 Week Low
- INZY $3.08
- GENC $14.15
- 52 Week High
- INZY $7.80
- GENC $24.88
- Technical
- Relative Strength Index (RSI)
- INZY 19.15
- GENC 53.92
- Support Level
- INZY $4.02
- GENC $21.22
- Resistance Level
- INZY $4.74
- GENC $22.82
- Average True Range (ATR)
- INZY 0.27
- GENC 0.68
- MACD
- INZY -0.11
- GENC 0.06
- Stochastic Oscillator
- INZY 2.65
- GENC 53.45
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.